phenylalanyl-prolyl-arginine-chloromethyl ketone and apyrase

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with apyrase in 1 studies

Compound Research Comparison

Studies (phenylalanyl-prolyl-arginine-chloromethyl ketone)	Trials (phenylalanyl-prolyl-arginine-chloromethyl ketone)	Recent Studies (post-2010) (phenylalanyl-prolyl-arginine-chloromethyl ketone)	Studies (apyrase)	Trials (apyrase)	Recent Studies (post-2010) (apyrase)
191	4	23	1,997	16	833

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brass, LF; Diamond, SL; Maloney, SF	1

Other Studies

1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and apyrase

Article	Year
P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions. Integrative biology : quantitative biosciences from nano to macro, 2010, Volume: 2, Issue:4 Topics: Amino Acid Chloromethyl Ketones; Apyrase; Cells, Cultured; Humans; Microfluidic Analytical Techniques; Platelet Adhesiveness; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis	2010

Article

Year

P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions.

Integrative biology : quantitative biosciences from nano to macro, 2010, Volume: 2, Issue:4

Topics: Amino Acid Chloromethyl Ketones; Apyrase; Cells, Cultured; Humans; Microfluidic Analytical Techniques; Platelet Adhesiveness; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis

2010